Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Isoforms of Wilms’ tumor suppressor gene (WT1) have distinct effects on mammary epithelial cells

Abstract

The role of WT1 (Wilm's tumor suppressor gene) in breast cancer is controversial, with evidence for both tumor-promoting and tumor-suppressing activities. In order to address this question, we expressed different WT1 isoforms in the mammary epithelial cell line H16N-2, which does not express endogenous WT1. Cells were stably transfected with either WT1 (−Ex5/−KTS) or WT1 (+Ex5/+KTS) under the control of the inducible metallothionein promoter. Induction of WT1 (−Ex5/−KTS) upregulated p21, causing a slowing of proliferation and a G2-phase cell cycle arrest. In artificial basement membrane, the WT1 (−Ex5/−KTS) isoform promoted the appearance of highly organized acinar cellular aggregates. In contrast, WT1 (+Ex5/+KTS) had no effect on p21 or proliferation, but rather caused an epithelial–mesenchymal transition and a redistribution of E-cadherin from the cell membrane to the cytoplasm. This isoform also causes the cellular aggregates growing in artificial basement membrane to appear significantly less organized than control cells. Thus, different WT1 isoforms have distinct effects in this cell line, suggesting that depending on the ratio of WT1 isoform expression in mammary epithelial cells, WT1 could function to either promote or suppress a transformed phenotype.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Barlund M, Forozan F, Kononen J, Bubendorf L, Chen Y, Bittner ML et al. (2000). Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. J Natl Cancer Inst 92: 1252–1259.

    Article  CAS  Google Scholar 

  • Davies RC, Calvio C, Bratt E, Larsson SH, Lamond AI, Hastie ND . (1998). WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes. Genes Dev 12: 3217–3225.

    Article  CAS  Google Scholar 

  • Englert C, Maheswaran S, Garvin AJ, Kreidberg J, Haber DA . (1997). Induction of p21 by the Wilms’ tumor suppressor gene WT1. Cancer Res 57: 1429–1434.

    CAS  PubMed  Google Scholar 

  • Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE . (1991). Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc Natl Acad Sci USA 88: 9618–9622.

    Article  CAS  Google Scholar 

  • Hewitt SM, Saunders GF . (1996). Differentially spliced exon 5 of the Wilms’ tumor gene WT1 modifies gene function. Anticancer Res 16: 621–626.

    CAS  PubMed  Google Scholar 

  • Inoue K, Tamaki H, Ogawa H, Oka Y, Soma T, Tatekawa T et al. (1998). Wilms’ tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells. Blood 91: 2969–2976.

    CAS  PubMed  Google Scholar 

  • Kolch W, Martiny-Baron G, Kieser A, Marme D . (1995). Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis. Breast Cancer Res Treat 36: 139–155.

    Article  CAS  Google Scholar 

  • Larsson SH, Charlieu JP, Miyagawa K, Engelkamp D, Rassoulzadegan M, Ross A et al. (1995). Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell 81: 391–401.

    Article  CAS  Google Scholar 

  • Lemoine NR, Barnes DM, Hollywood DP, Hughes CM, Smith P, Dublin E et al. (1992). Expression of the ERBB3 gene product in breast cancer. Br J Cancer 66: 1116–1121.

    Article  CAS  Google Scholar 

  • Lo HW, Hsu SC, Hung MC . (2005). EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization. Breast Cancer Res Treat 95: 1–8.

    Google Scholar 

  • Loeb DM . (2006). WT1 influences apoptosis through transcriptional regulation of Bcl-2 family members. Cell Cycle 5: 1249–1253.

    Article  CAS  Google Scholar 

  • Loeb DM, Evron E, Patel CB, Sharma PM, Niranjan B, Buluwela L et al. (2001). Wilms’ tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation. Cancer Res 61: 921–925.

    CAS  Google Scholar 

  • Loeb DM, Korz D, Katsnelson M, Burwell EA, Friedman AD, Sukumar S . (2002). Cyclin E is a target of WT1 transcriptional repression. J Biol Chem 277: 19627–19632.

    Article  CAS  Google Scholar 

  • Loeb DM, Summers JL, Burwell EA, Korz D, Friedman AD, Sukumar S . (2003). An isoform of the Wilms’ tumor suppressor gene potentiates granulocytic differentiation. Leukemia 17: 965–971.

    Article  CAS  Google Scholar 

  • Maheswaran S, Park S, Bernard A, Morris JF, Rauscher FJd, Hill DE et al. (1993). Physical and functional interaction between WT1 and p53 proteins. Proc Natl Acad Sci USA 90: 5100–5104.

    Article  CAS  Google Scholar 

  • Miyoshi Y, Ando A, Egawa C, Taguchi T, Tamaki Y, Tamaki H et al. (2002). High expression of Wilms’ tumor suppressor gene predicts poor prognosis in breast cancer patients. Clin Cancer Res 8: 1167–1171.

    CAS  PubMed  Google Scholar 

  • Natoli TA, McDonald A, Alberta JA, Taglienti ME, Housman DE, Kreidberg JA . (2002). A mammal-specific exon of WT1 is not required for development or fertility. Mol Cell Biol 22: 4433–4438.

    Article  CAS  Google Scholar 

  • Reizner N, Maor S, Sarfstein R, Abramovitch S, Welshons WV, Curran EM et al. (2005). The WT1 Wilms’ tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells. J Mol Endocrinol 35: 135–144.

    Article  CAS  Google Scholar 

  • Reynolds PA, Smolen GA, Palmer RE, Sgroi D, Yajnik V, Gerald WL et al. (2003). Identification of a DNA-binding site and transcriptional target for the EWS-WT1(+KTS) oncoprotein. Genes Dev 17: 2094–2107.

    Article  CAS  Google Scholar 

  • Silberstein GB, Van Horn K, Strickland P, Roberts Jr CT, Daniel CW . (1997). Altered expression of the WT1 Wilms tumor suppressor gene in human breast cancer. Proc Natl Acad Sci USA 94: 8132–8137.

    Article  CAS  Google Scholar 

  • Udabage L, Brownlee GR, Nilsson SK, Brown TJ . (2005). The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer. Exp Cell Res 310: 205–217.

    Article  CAS  Google Scholar 

  • Velona T, Abbiati L, Beretta B, Gaiaschi A, Flauto U, Tagliabue P et al. (1999). Protein profiles in breast milk from mothers delivering term and preterm babies. Pediatr Res 45: 658–663.

    Article  CAS  Google Scholar 

  • Zapata-Benavides P, Tuna M, Lopez-Berestein G, Tari AM . (2002). Downregulation of Wilms’ tumor 1 protein inhibits breast cancer proliferation. Biochem Biophys Res Commun 295: 784–790.

    Article  CAS  Google Scholar 

  • Zhang TF, Yu SQ, Guan LS, Wang ZY . (2003). Inhibition of breast cancer cell growth by the Wilms’ tumor suppressor WT1 is associated with a destabilization of beta-catenin. Anticancer Res 23: 3575–3584.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful to Venu Raman, Alan Friedman, and Robert Arceci for critical review of this article. This work was supported by grants from Flight Attendant Medical Research Institute Young Clinical Scholar Award no. 012531 (DML), Children's Cancer Foundation (DML) and National Cancer Institute T32CA60441 (LAS).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D M Loeb.

Additional information

Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Burwell, E., McCarty, G., Simpson, L. et al. Isoforms of Wilms’ tumor suppressor gene (WT1) have distinct effects on mammary epithelial cells. Oncogene 26, 3423–3430 (2007). https://doi.org/10.1038/sj.onc.1210127

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1210127

Keywords

This article is cited by

Search

Quick links